Withings announced at CES 2026 (Las Vegas, Jan. 6-9) that it will offer Abbott’s Lingo over-the-counter continuous glucose monitor (CGM) to Withings users. The partnership aims to empower millions of people to better understand their metabolism by continuously tracking their glucose, and taking meaningful control of their health and well-being.

In the initial phase of the Abbott Lingo-Withings partnership, users can access their glucose data by pairing the Withings app with Apple Health (iOS users) and Health Connect by Android. Early this quarter, all users will be able to access their glucose data directly from the Withings app through a direct API between Abbott’s Lingo app and Withings.

“True wellness begins with understanding every part of your health data,” Withings Founder/President Eric Carreel said. “With Withings’ smart scales, blood-pressure monitors, and wearables, individuals can track biomarkers such as pulse wave velocity (arterial stiffness), vascular age, fat vs. muscle vs. visceral fat, resting heart rate, body water, bone mass, and more. Layered with insights gained from glucose data from Abbott’s Lingo, this gives a uniquely rich and holistic view of long-term well-being. Through this partnership, we’re making it easier for individuals to take charge of their health journey—with insight, awareness, and confidence.”

Continuous Glucose Tracking: Essential for Optimal Metabolic Health

Glucose monitoring plays a critical role in understanding overall health and metabolic function. Glucose data can help provide crucial understanding of the ways food, activity, and stress impact energy levels, mood, and sleep quality. Maintaining healthy glucose is shown to reduce the risk of insulin resistance, Type 2 diabetes, and heart disease. More than 98 million Americans have pre-diabetes, a leading precursor to the onset of Type 2 diabetes. The integration of Abbott’s Lingo glucose data with the Withings ecosystem is specifically designed to encourage consumers to take control of their health.

“Abbott has been pioneering glucose tracking for more than a decade and we are excited to bring glucose data to consumers focused on improving their overall health and wellness with the Lingo over-the-counter CGM,” said Olivier Ropars, division vice president of Abbott’s Lingo business. “By bringing glucose data to the Withings community, we can help empower them to build better habits to improve their overall metabolic health. Improving metabolic health can reduce the risk of chronic conditions, including prediabetes, and understanding glucose is a powerful way to unlock insights on overall health.”

Through the two companies’ partnership, users can seamlessly track their glucose data and health metrics—all in the Withings app.

Withings users already can monitor more than 90 biomarkers through connected devices such as smart scales, watches, blood pressure monitors, and more. By integrating continuous glucose monitoring, this collaboration empowers individuals to gain deeper and more personalized insights into the ways in which their behaviors and biology influence overall metabolic health.

The collaboration with Abbottp expands Withings’ footprint in metabolic health by combining its connected medical devices to empower and support various health journeys. Withings’ U.S. users can now access their glucose data using the Lingo app. Lingo CGMs are available for purchase on Withings’ U.S. website (includes two Lingo biosensors).

A pioneer in real-life health monitoring, Withings created the first connected scale in 2009 and has continually innovated since then to offer an ecosystem of clinically validated connected objects, used by more than 15 million people worldwide as well as by numerous healthcare centers and research institutes. The Withings ecosystem measures more than 90 biomarkers. It includes connected scales, true health platforms, and exclusive biomarkers such as nerve health score and pulse wave velocity that attests to cardiovascular age and alerts to arterial stiffness caused notably by hypertension. It includes a sleep analyzer detecting sleep cycles, wake phases, and sleep apnea. It also features hybrid connected watches that notably track heart rate and its variations day and night, perform a medical-grade electrocardiogram to detect pathologies like atrial fibrillation, or monitor blood oxygenation. Its connected blood pressure monitors allow for home monitoring of blood pressure evolution, thanks to sharing reliable and exhaustive measurement reports with a doctor, and can integrate a stethoscope to detect at-home valvular heart disease, which is more frequent in case of arterial hypertension.

The Lingo Glucose System is intended for users 18 years and older not on insulin. It is not intended to diagnose diseases, including diabetes. The Lingo program does not guarantee that all users will achieve the same results.